Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 125 entries
Sorted by: Best Match Show Resources per page
The current place of learning objectives in paediatrics.

Medical education

Foulds DM, Sterling R, Wood PR, Sterling J, Littlefield JH.
PMID: 2796793
Med Educ. 1989 Sep;23(5):407-8. doi: 10.1111/j.1365-2923.1989.tb00893.x.

No abstract available.

Cite
Foulds DM, Sterling R, Wood PR, et al. The current place of learning objectives in paediatrics. Med Educ. 1989;23(5):407-8doi: 10.1111/j.1365-2923.1989.tb00893.x.
Foulds, D. M., Sterling, R., Wood, P. R., Sterling, J., & Littlefield, J. H. (1989). The current place of learning objectives in paediatrics. Medical education, 23(5), 407-8. https://doi.org/10.1111/j.1365-2923.1989.tb00893.x
Foulds, D M, et al. "The current place of learning objectives in paediatrics." Medical education vol. 23,5 (1989): 407-8. doi: https://doi.org/10.1111/j.1365-2923.1989.tb00893.x
Foulds DM, Sterling R, Wood PR, Sterling J, Littlefield JH. The current place of learning objectives in paediatrics. Med Educ. 1989 Sep;23(5):407-8. doi: 10.1111/j.1365-2923.1989.tb00893.x. PMID: 2796793.
Copy Download .nbib Format: NLM
A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Hanchard NA, Moulds JM, Belmont JW, Chen A.
PMID: 25670933
Transfus Med Hemother. 2014 Nov;41(6):453-61. doi: 10.1159/000369079. Epub 2014 Nov 07.

BACKGROUND: A selective susceptibility of certain individuals to form multiple alloantibodies in response to red cell transfusion is well-recognized in clinical practice, and is a particular problem in persons with sickle cell disease (SCD). The reason for this differential...

Cite
Hanchard NA, Moulds JM, Belmont JW, et al. A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease. Transfus Med Hemother. 2014;41(6):453-61doi: 10.1159/000369079.
Hanchard, N. A., Moulds, J. M., Belmont, J. W., & Chen, A. (2014). A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 41(6), 453-61. https://doi.org/10.1159/000369079
Hanchard, Neil A, et al. "A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 41,6 (2014): 453-61. doi: https://doi.org/10.1159/000369079
Hanchard NA, Moulds JM, Belmont JW, Chen A. A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease. Transfus Med Hemother. 2014 Nov;41(6):453-61. doi: 10.1159/000369079. Epub 2014 Nov 07. PMID: 25670933; PMCID: PMC4280456.
Copy Download .nbib Format: NLM
Recovery rates, enhanced oil recovery and technological limits.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences

Muggeridge A, Cockin A, Webb K, Frampton H, Collins I, Moulds T, Salino P.
PMID: 24298076
Philos Trans A Math Phys Eng Sci. 2013 Dec 02;372(2006):20120320. doi: 10.1098/rsta.2012.0320. Print 2014 Jan 13.

Enhanced oil recovery (EOR) techniques can significantly extend global oil reserves once oil prices are high enough to make these techniques economic. Given a broad consensus that we have entered a period of supply constraints, operators can at last...

Cite
Muggeridge A, Cockin A, Webb K, et al. Recovery rates, enhanced oil recovery and technological limits. Philos Trans A Math Phys Eng Sci. 2013;372(2006):20120320doi: 10.1098/rsta.2012.0320.
Muggeridge, A., Cockin, A., Webb, K., Frampton, H., Collins, I., Moulds, T., & Salino, P. (2014). Recovery rates, enhanced oil recovery and technological limits. Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 372(2006), 20120320. https://doi.org/10.1098/rsta.2012.0320
Muggeridge, Ann, et al. "Recovery rates, enhanced oil recovery and technological limits." Philosophical transactions. Series A, Mathematical, physical, and engineering sciences vol. 372,2006 (2014): 20120320. doi: https://doi.org/10.1098/rsta.2012.0320
Muggeridge A, Cockin A, Webb K, Frampton H, Collins I, Moulds T, Salino P. Recovery rates, enhanced oil recovery and technological limits. Philos Trans A Math Phys Eng Sci. 2013 Dec 02;372(2006):20120320. doi: 10.1098/rsta.2012.0320. Print 2014 Jan 13. PMID: 24298076; PMCID: PMC3866386.
Copy Download .nbib Format: NLM
Review: Modern molecular genetic techniques.

Immunohematology

Moulds JM.
PMID: 15946092
Immunohematology. 1993;9(3):63-7.

No abstract available.

Cite
Moulds JM. Review: Modern molecular genetic techniques. Immunohematology. 1993;9(3):63-7
Moulds, J. M. (1993). Review: Modern molecular genetic techniques. Immunohematology, 9(3), 63-7.
Moulds, J M. "Review: Modern molecular genetic techniques." Immunohematology vol. 9,3 (1993): 63-7.
Moulds JM. Review: Modern molecular genetic techniques. Immunohematology. 1993;9(3):63-7. PMID: 15946092.
Copy Download .nbib Format: NLM
Alkaline peroxide delignification of agricultural residues to enhance enzymatic saccharification.

Biotechnology and bioengineering

Gould JM.
PMID: 18551585
Biotechnol Bioeng. 1984 Jan;26(1):46-52. doi: 10.1002/bit.260260110.

Approximately one-half of the lignin and most of the hemicellulose present in agricultural residues such as wheat straw and corn stover are solubilized when the residue is treated at 25 degrees C in an alkaline solution of hydrogen peroxide....

Cite
Gould JM. Alkaline peroxide delignification of agricultural residues to enhance enzymatic saccharification. Biotechnol Bioeng. 1984;26(1):46-52doi: 10.1002/bit.260260110.
Gould, J. M. (1984). Alkaline peroxide delignification of agricultural residues to enhance enzymatic saccharification. Biotechnology and bioengineering, 26(1), 46-52. https://doi.org/10.1002/bit.260260110
Gould, J M. "Alkaline peroxide delignification of agricultural residues to enhance enzymatic saccharification." Biotechnology and bioengineering vol. 26,1 (1984): 46-52. doi: https://doi.org/10.1002/bit.260260110
Gould JM. Alkaline peroxide delignification of agricultural residues to enhance enzymatic saccharification. Biotechnol Bioeng. 1984 Jan;26(1):46-52. doi: 10.1002/bit.260260110. PMID: 18551585.
Copy Download .nbib Format: NLM
Genetic and environmental considerations for evaluating crown position of wheat.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Poulos JM, Allan RE.
PMID: 24227242
Theor Appl Genet. 1989 Sep;78(3):359-64. doi: 10.1007/BF00265297.

Crown position affects winter survival of fallsown wheat (Triticum aestivum L.) Direct or indirect selection for crown depth has been little practiced. Reports have suggested that short subcrown internode length was closely related to semidwarf plant height and that...

Cite
Poulos JM, Allan RE. Genetic and environmental considerations for evaluating crown position of wheat. Theor Appl Genet. 1989;78(3):359-64doi: 10.1007/BF00265297.
Poulos, J. M., & Allan, R. E. (1989). Genetic and environmental considerations for evaluating crown position of wheat. TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 78(3), 359-64. https://doi.org/10.1007/BF00265297
Poulos, J M, and Allan, R E. "Genetic and environmental considerations for evaluating crown position of wheat." TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik vol. 78,3 (1989): 359-64. doi: https://doi.org/10.1007/BF00265297
Poulos JM, Allan RE. Genetic and environmental considerations for evaluating crown position of wheat. Theor Appl Genet. 1989 Sep;78(3):359-64. doi: 10.1007/BF00265297. PMID: 24227242.
Copy Download .nbib Format: NLM
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes.

Oncotarget

Meunier M, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet M, Wang Y, Faure P, Szymanski G, Duployez N, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Park S.
PMID: 29285268
Oncotarget. 2017 Nov 06;8(62):105510-105524. doi: 10.18632/oncotarget.22299. eCollection 2017 Dec 01.

Anemia is a frequent cytopenia in myelodysplastic syndromes (MDS) and most patients require red blood cell transfusion resulting in iron overload (IO). Deferasirox (DFX) has become the standard treatment of IO in MDS and it displays positive effects on...

Cite
Meunier M, Ancelet S, Lefebvre C, et al. Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes. Oncotarget. 2017;8(62):105510-105524doi: 10.18632/oncotarget.22299.
Meunier, M., Ancelet, S., Lefebvre, C., Arnaud, J., Garrel, C., Pezet, M., Wang, Y., Faure, P., Szymanski, G., Duployez, N., Preudhomme, C., Biard, D., Polack, B., Cahn, J. Y., Moulis, J. M., & Park, S. (2017). Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes. Oncotarget, 8(62), 105510-105524. https://doi.org/10.18632/oncotarget.22299
Meunier, Mathieu, et al. "Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes." Oncotarget vol. 8,62 (2017): 105510-105524. doi: https://doi.org/10.18632/oncotarget.22299
Meunier M, Ancelet S, Lefebvre C, Arnaud J, Garrel C, Pezet M, Wang Y, Faure P, Szymanski G, Duployez N, Preudhomme C, Biard D, Polack B, Cahn JY, Moulis JM, Park S. Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes. Oncotarget. 2017 Nov 06;8(62):105510-105524. doi: 10.18632/oncotarget.22299. eCollection 2017 Dec 01. PMID: 29285268; PMCID: PMC5739655.
Copy Download .nbib Format: NLM
E-cigarettes are less harmful than smoking.

Lancet (London, England)

Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Polosa R, Ramsey J, Sweanor D.
PMID: 27025332
Lancet. 2016 Mar 19;387(10024):1160-2. doi: 10.1016/S0140-6736(15)00253-6.

No abstract available.

Cite
Nutt DJ, Phillips LD, Balfour D, et al. E-cigarettes are less harmful than smoking. Lancet. 2016;387(10024):1160-2doi: 10.1016/S0140-6736(15)00253-6.
Nutt, D. J., Phillips, L. D., Balfour, D., Curran, H. V., Dockrell, M., Foulds, J., Fagerstrom, K., Letlape, K., Polosa, R., Ramsey, J., & Sweanor, D. (2016). E-cigarettes are less harmful than smoking. Lancet (London, England), 387(10024), 1160-2. https://doi.org/10.1016/S0140-6736(15)00253-6
Nutt, David J, et al. "E-cigarettes are less harmful than smoking." Lancet (London, England) vol. 387,10024 (2016): 1160-2. doi: https://doi.org/10.1016/S0140-6736(15)00253-6
Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Polosa R, Ramsey J, Sweanor D. E-cigarettes are less harmful than smoking. Lancet. 2016 Mar 19;387(10024):1160-2. doi: 10.1016/S0140-6736(15)00253-6. PMID: 27025332.
Copy Download .nbib Format: NLM
Measurement of Electronic Cigarette Frequency of Use Among Smokers Participating in a Randomized Controlled Trial.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Yingst J, Foulds J, Veldheer S, Cobb CO, Yen MS, Hrabovsky S, Allen SI, Bullen C, Eissenberg T.
PMID: 30365024
Nicotine Tob Res. 2020 Apr 21;22(5):699-704. doi: 10.1093/ntr/nty233.

BACKGROUND: The United States Food and Drug Administration has prioritized understanding the dependence potential of electronic cigarettes (e-cigs). Dependence is often estimated in part by examining frequency of use; however measures of e-cig use are not well developed because...

Cite
Yingst J, Foulds J, Veldheer S, et al. Measurement of Electronic Cigarette Frequency of Use Among Smokers Participating in a Randomized Controlled Trial. Nicotine Tob Res. 2020;22(5):699-704doi: 10.1093/ntr/nty233.
Yingst, J., Foulds, J., Veldheer, S., Cobb, C. O., Yen, M. S., Hrabovsky, S., Allen, S. I., Bullen, C., & Eissenberg, T. (2020). Measurement of Electronic Cigarette Frequency of Use Among Smokers Participating in a Randomized Controlled Trial. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 22(5), 699-704. https://doi.org/10.1093/ntr/nty233
Yingst, Jessica, et al. "Measurement of Electronic Cigarette Frequency of Use Among Smokers Participating in a Randomized Controlled Trial." Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco vol. 22,5 (2020): 699-704. doi: https://doi.org/10.1093/ntr/nty233
Yingst J, Foulds J, Veldheer S, Cobb CO, Yen MS, Hrabovsky S, Allen SI, Bullen C, Eissenberg T. Measurement of Electronic Cigarette Frequency of Use Among Smokers Participating in a Randomized Controlled Trial. Nicotine Tob Res. 2020 Apr 21;22(5):699-704. doi: 10.1093/ntr/nty233. PMID: 30365024; PMCID: PMC7171268.
Copy Download .nbib Format: NLM
Quitting electronic cigarettes: Factors associated with quitting and quit attempts in long-term users.

Addictive behaviors

Sobieski E, Yingst J, Foulds J.
PMID: 34979427
Addict Behav. 2021 Dec 23;127:107220. doi: 10.1016/j.addbeh.2021.107220. Epub 2021 Dec 23.

Some electronic cigarette (e-cigarette) users are interested in quitting e-cigarette use, though few studies have assessed what factors contribute to this interest. This study aimed to identify factors associated with e-cigarette quitting interest and quitting behaviors in exclusive, long-term...

Cite
Sobieski E, Yingst J, Foulds J. Quitting electronic cigarettes: Factors associated with quitting and quit attempts in long-term users. Addict Behav. 2021;127:107220doi: 10.1016/j.addbeh.2021.107220.
Sobieski, E., Yingst, J., & Foulds, J. (2021). Quitting electronic cigarettes: Factors associated with quitting and quit attempts in long-term users. Addictive behaviors, 127107220. https://doi.org/10.1016/j.addbeh.2021.107220
Sobieski, Eric, et al. "Quitting electronic cigarettes: Factors associated with quitting and quit attempts in long-term users." Addictive behaviors vol. 127 (2021): 107220. doi: https://doi.org/10.1016/j.addbeh.2021.107220
Sobieski E, Yingst J, Foulds J. Quitting electronic cigarettes: Factors associated with quitting and quit attempts in long-term users. Addict Behav. 2021 Dec 23;127:107220. doi: 10.1016/j.addbeh.2021.107220. Epub 2021 Dec 23. PMID: 34979427.
Copy Download .nbib Format: NLM
Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models.

Leukemia

Dutta A, Nath D, Yang Y, Le BT, Rahman MF, Faughnan P, Wang Z, Stuver M, He R, Tan W, Hutchison RE, Foulks JM, Warner SL, Zang C, Mohi G.
PMID: 34741118
Leukemia. 2021 Nov 05; doi: 10.1038/s41375-021-01464-2. Epub 2021 Nov 05.

Myelofibrosis (MF) is the deadliest form of myeloproliferative neoplasm (MPN). The JAK inhibitor Ruxolitinib can reduce constitutional symptoms but it does not substantially improve bone marrow fibrosis. Pim1 expression is significantly elevated in MPN/MF hematopoietic progenitors. Here, we show...

Cite
Dutta A, Nath D, Yang Y, et al. Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models. Leukemia. 2021;doi: 10.1038/s41375-021-01464-2.
Dutta, A., Nath, D., Yang, Y., Le, B. T., Rahman, M. F., Faughnan, P., Wang, Z., Stuver, M., He, R., Tan, W., Hutchison, R. E., Foulks, J. M., Warner, S. L., Zang, C., & Mohi, G. (2021). Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models. Leukemia, . https://doi.org/10.1038/s41375-021-01464-2
Dutta, Avik, et al. "Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models." Leukemia vol. (2021). doi: https://doi.org/10.1038/s41375-021-01464-2
Dutta A, Nath D, Yang Y, Le BT, Rahman MF, Faughnan P, Wang Z, Stuver M, He R, Tan W, Hutchison RE, Foulks JM, Warner SL, Zang C, Mohi G. Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models. Leukemia. 2021 Nov 05; doi: 10.1038/s41375-021-01464-2. Epub 2021 Nov 05. PMID: 34741118.
Copy Download .nbib Format: NLM
Psychometric evaluation of the Patient-Reported Outcomes Measurement Information System (PROMIS)Nicotine Dependence Item Bankfor use with electronic cigarettes.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Morean ME, Krishnan-Sarin S, Sussman S, Foulds J, Fishbein H, Grana R, O'Malley SS.
PMID: 31254382
Nicotine Tob Res. 2020 Oct 29;22(11):2123. doi: 10.1093/ntr/ntz095.

No abstract available.

Cite
Morean ME, Krishnan-Sarin S, Sussman S, et al. Psychometric evaluation of the Patient-Reported Outcomes Measurement Information System (PROMIS)Nicotine Dependence Item Bankfor use with electronic cigarettes. Nicotine Tob Res. 2020;22(11):2123doi: 10.1093/ntr/ntz095.
Morean, M. E., Krishnan-Sarin, S., Sussman, S., Foulds, J., Fishbein, H., Grana, R., & O'Malley, S. S. (2020). Psychometric evaluation of the Patient-Reported Outcomes Measurement Information System (PROMIS)Nicotine Dependence Item Bankfor use with electronic cigarettes. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 22(11), 2123. https://doi.org/10.1093/ntr/ntz095
Morean, M E, et al. "Psychometric evaluation of the Patient-Reported Outcomes Measurement Information System (PROMIS)Nicotine Dependence Item Bankfor use with electronic cigarettes." Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco vol. 22,11 (2020): 2123. doi: https://doi.org/10.1093/ntr/ntz095
Morean ME, Krishnan-Sarin S, Sussman S, Foulds J, Fishbein H, Grana R, O'Malley SS. Psychometric evaluation of the Patient-Reported Outcomes Measurement Information System (PROMIS)Nicotine Dependence Item Bankfor use with electronic cigarettes. Nicotine Tob Res. 2020 Oct 29;22(11):2123. doi: 10.1093/ntr/ntz095. PMID: 31254382; PMCID: PMC7593357.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 125 entries